相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD270
- 级别:
CD270 (HVEM, TR2) Antibody
- 目录编号:
CD270 (HVEM, TR2) Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
CD270 (HVEM, TR2) Antibody
- 抗体英文名:
TotalSeq™-C0020 anti-human CD270 (HVEM, TR2) Antibody
- 抗体名:
CD270 (HVEM, TR2) Antibody
- 标记物:
CD270 (HVEM, TR2) Antibody
- 宿主:
小鼠
- 适应物种:
人
- 免疫原:
CD270 (HVEM, TR2) Antibody
- 亚型:
CD270 (HVEM, TR2) Antibody
- 形态:
CD270 (HVEM, TR2) Antibody
- 应用范围:
PG
- 保存条件:
2-8℃
- 浓度:
0.5 mg/ml
- 规格:
10 µg
TotalSeq™-C0020 anti-human CD270 (HVEM, TR2) Antibody详细如下:
Description :The 122 antibody recognizes human HVEM also known as herpesvirus entry mediator A, tumornecrosis factor receptor superfamily, member 14, TNFRSF14, and tumor necrosis factorreceptor like 2. HVEM, a member of the TNFR superfamily, is a type I transmembrane proteincontaining 2 TNF receptor domains with a predicted molecular weight of approximately 30 kD.HVEM is widely expressed in blood vessels, brain, heart, kidney, liver, lung, prostate, spleen,thymus and other organs. Resting T cells and naïve and memory B cells express high levels ofHVEM as well. In humans, HVEM is not expressed in germinal center B cells. Immature dendriticcells express high levels of HVEM that is downregulated upon maturation. HVEM plays animportant role in herpes simplex virus pathogenesis by enhancing entry into cells. Signalingthrough HVEM activates JNK1, NF-κB and AP-1 to control gene expression in response toinfection or cellular stress and activate the immune response. HVEM binds to LIGHT and hasalso been shown to associate with several other proteins including TRAF1, TRAF2, TRAF3,TRAF5, B and T lymphocyte associated protein (BTLA), and estrogen receptor alpha.
Verified Reactivity :Human
Reported Reactivity :African Green, Baboon, Cynomolgus, Rhesus
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :Recombinant human HVEM protein
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 1 mM EDTA
Preparation :The antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer underoptimal conditions.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application :PG - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-C antibodies arecompatible with 10x Genomics Chromium Single Cell Immune Profiling Solution.
To maximize performance, it is strongly recommended that the reagent be titrated for eachapplication, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2- 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to thecell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent fortitration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™protocol for specific staining instructions.
Description :The 122 antibody recognizes human HVEM also known as herpesvirus entry mediator A, tumornecrosis factor receptor superfamily, member 14, TNFRSF14, and tumor necrosis factorreceptor like 2. HVEM, a member of the TNFR superfamily, is a type I transmembrane proteincontaining 2 TNF receptor domains with a predicted molecular weight of approximately 30 kD.HVEM is widely expressed in blood vessels, brain, heart, kidney, liver, lung, prostate, spleen,thymus and other organs. Resting T cells and naïve and memory B cells express high levels ofHVEM as well. In humans, HVEM is not expressed in germinal center B cells. Immature dendriticcells express high levels of HVEM that is downregulated upon maturation. HVEM plays animportant role in herpes simplex virus pathogenesis by enhancing entry into cells. Signalingthrough HVEM activates JNK1, NF-κB and AP-1 to control gene expression in response toinfection or cellular stress and activate the immune response. HVEM binds to LIGHT and hasalso been shown to associate with several other proteins including TRAF1, TRAF2, TRAF3,TRAF5, B and T lymphocyte associated protein (BTLA), and estrogen receptor alpha.
Verified Reactivity :Human
Reported Reactivity :African Green, Baboon, Cynomolgus, Rhesus
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :Recombinant human HVEM protein
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and 1 mM EDTA
Preparation :The antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer underoptimal conditions.
Concentration :0.5 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application :PG - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-C antibodies arecompatible with 10x Genomics Chromium Single Cell Immune Profiling Solution.
To maximize performance, it is strongly recommended that the reagent be titrated for eachapplication, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2- 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to thecell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent fortitration is ≤ 1.0 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™protocol for specific staining instructions.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Cheung TC, et al. 2010. J. Immunol. 185:1949. PubMed
2. Hobo W, et al. 2012. J Immunol. 189:39. PubMed.
1. Cheung TC, et al. 2010. J. Immunol. 185:1949. PubMed
2. Hobo W, et al. 2012. J Immunol. 189:39. PubMed.
文献支持
TotalSeq™-C0020 抗人 CD270 (HVEM, TR2) 抗体
¥6500










